Related Experiment Video
Updated: Jun 18, 2026

Tricolor Transgenic Murine Model for Studying Growth Plate Injury
Published on: September 6, 2024
Promoting growth in chronic inflammatory disease: lessons from studies of the growth plate
1Bone and Endocrine Research Group, Division of Developmental Medicine, University of Glasgow, Royal Hospital for Sick Children, Glasgow, UK.
Insights
Growth disorders in children with chronic inflammation are linked to growth hormone-insulin-like growth factor I (IGF-I) axis disruption. While IGF-I therapy helps, managing inflammation and glucocorticoids remains key for growth.
Area of Science:
- Pediatric endocrinology
- Inflammatory diseases
- Growth disorders
Background:
- Children with chronic inflammatory diseases often experience growth disorders.
- Growth is regulated by the growth hormone-insulin-like growth factor I (IGF-I) axis.
- Glucocorticoids (GCs) and proinflammatory cytokines impact this axis and growth plate function.
Purpose of the Study:
- To understand how GCs and cytokines affect the growth plate.
- To explore the rationale for growth-promoting therapies in children with inflammation and growth retardation.
Main Methods:
- Review of recent advances in understanding GC and cytokine effects on the growth plate.
- Analysis of the impact on the growth hormone-IGF-I axis.
- Evaluation of potential therapeutic interventions.
Main Results:
- Both GCs and proinflammatory cytokines negatively impact growth plate chondrogenesis.
- Increased local IGF-I exposure can partially ameliorate these adverse effects.
- IGF-I intervention does not fully normalize growth plate function.
Conclusions:
- Effective control of the inflammatory disease process is crucial for improving growth.
- Judicious use of GCs remains a cornerstone of management.
- While IGF-I shows promise, it does not completely resolve growth plate abnormalities.
Background:
Growth disorders are commonly observed in children with chronic inflammatory disease. It is likely that these disorders are mediated by a combination of factors, including the disease process and its treatment (with drugs such as glucocorticoids [GCs]). These factors affect the growth hormone-insulin-like growth factor I (IGF-I) axis, which is crucial for promoting linear growth at the level of the growth plate. Recent advances in our knowledge of the effects of GCs and proinflammatory cytokines on the growth plate have led to an improved understanding of the biological rationale for the use of growth-promoting therapy in children with chronic inflammatory disease and concurrent growth retardation.
Conclusions:
Both GCs and proinflammatory cytokines can adversely affect a number of components of growth plate chondrogenesis, and these effects can be ameliorated by raising local IGF-I exposure. However, this intervention does not lead to complete normalization of the growth plate. In children with chronic inflammation, the cornerstone of improving growth remains the judicious use of GCs while ensuring effective control of the disease process.
Related Concept Videos
Growth of Cartilage and Bone Tissue
Chronic Inflammation: Introduction
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Nature and Nurture

